Stocks · Health care · Pharmaceutical Preparations

Latigo Biotherapeutics, Inc.

LTGO
United States Fiscal year ends December CIK 0002056611
$16.00 +8.18% Close, 9 Oct 2026
Price $16.00 −29.82% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 7 Aug 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Financial statements

Nothing filed here yet

No statements have been read for LTGO. They arrive with the nightly refresh; a company joins the screen the first time one is.